Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103534
Filing Date
2025-08-06
Accepted
2025-08-06 07:12:53
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q upb-20250630.htm   iXBRL 10-Q 2951048
2 EX-31.1 upb-ex31_1.htm EX-31.1 17773
3 EX-31.2 upb-ex31_2.htm EX-31.2 17590
4 EX-32.1 upb-ex32_1.htm EX-32.1 15990
  Complete submission text file 0000950170-25-103534.txt   9960268

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT upb-20250630.xsd EX-101.SCH 1072543
77 EXTRACTED XBRL INSTANCE DOCUMENT upb-20250630_htm.xml XML 1842528
Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Filer) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42366 | Film No.: 251187432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)